All Type of News
Registered medicines are now available to acquire separate approval as orphan drug
In order to promote manufacturing of orphan drugs, a system will be improved for already registered medicines to acquire separate product approval as am orphan drug.
The Minister of Food and Drug Safety(Minister Youn...
Pharmas to control wholesalers over rebates through ‘CP’ and ‘Fair Trade Agreement’
While a pharmaceutical company started to intensively control its client wholesalers as part of the rebate eradication plan, it has been spread to other pharmaceutical companies.
Recently, a pharmaceutical company se...
MFDS announces 2,020 products applied differentials for small packaging rule
On 13 September, the Ministry of Food and Drug Safety(MFDS) announced 2,020 products which do not follow the differential small-quantity packaging standards for medicines.
The announcement indicated 655 products for ...
Tonymoly gives up acquisition of Tai Guk Pharm, largest dermatologic product company
Tonymoly, a cosmetic brand, gave an official notice to acquire Tai Guk Pharm(decided to acquire 5.826 million shares, KRW 14 billion), the Korea’s largest pharmaceutical company specializing in dermatologic products, ...
Health and Welfare Committee conducts parliamentary inspections between 12th and 31st of October
Regular parliamentary inspections of the government offices will be conducted between the 12th and 31st of October.
Ruling and opposing parties of the National Assembly Health and Welfare Committee agreed to have ins...
Daewoong Pharmaceutical acquires preferential sale right in KRW 150 billion hepatitis B generic marketDaewoong Pharmaceutical will enter the market of ‘tenofovir,’ a hepatitis B treatment, worth of approximately KRW 150 billion.
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announ...
|
Pharmas extend rebate control to client distributors
While the pharmaceutical industry has recently had rebate issues once again, individual pharmaceutical companies are tightening their own rules to eradicate rebates.
They have only performed a program to eradicate re...
TissueGene receives a grand for ‘Invossa’ development from U.S. Maryland
TissueGene(CEO Bum-Seop Lee/Woo-Seok Lee) Co-CEO Woo-Seok Lee participated in a reception at Habib House, the U.S. Ambassador to South Korea’s residence in Seoul, hosted by officials the Maryland Department of Commerc...
Dongwha Pharm-MSD Korea signs license agreement of antidepressant ‘Remeron’
Dongwha Pharm(CEO Ji-Hoon Sohn) signed a MSD’s exclusive sale and supply agreement of Remeron(generic name: mirtazapine), a MSD’s antidepressant, in Korea on the 8th of September.
Remeron, a MSD’s NaSSA(antidepressan...
BUKDA criticizes distribution business invested by medical institutes
The Busan, Ulsan & Kyungnam Distribution Association has made a strong criticism over distribution companies invested jointly by medical institutes.
The Busan, Ulsan & Kyungnam Distribution Association(President Cheo...
